Hiroyuki Yoshida

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Topics

Metastatic Colorectal Cancer

Top Venues

JCO precision oncology

Journal of gynecologic oncology

Archives of gynecology and obstetrics

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B Runnebaum, Isabelle L Ray-Coquard
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 7 (2023)
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B Runnebaum, Isabelle L Ray-Coquard
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 7 (2023)
Hiroyuki Yoshida, Keiichi Fujiwara
Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum-refractory/resistant ovarian cancer. Cancer medicine (2023)
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B Runnebaum, Isabelle L Ray-Coquard
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 7 (2023)
Keiichi Fujiwara, Hiroyuki Fujiwara, Hiroyuki Yoshida, Toyomi Satoh, Kan Yonemori, Shoji Nagao, Takashi Matsumoto, Hiroaki Kobayashi, Hughes Bourgeois, Philipp Harter, Anna Maria Mosconi, Isabel Palacio Vazquez, Reinthaller Alexander, Tomoko Fujita, Philip Rowe, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial. Journal of gynecologic oncology 32 (5) (2021)
Hiroyuki Yoshida, Daisuke Shintani, Aiko Ogasawara, Keiichi Fujiwara
Feasibility and response to nedaplatin monotherapy in older patients with ovarian cancer. Archives of gynecology and obstetrics 296 (4) (2017)
Tadaaki Nishikawa, Kosei Hasegawa, Akira Yabuno, Hiroyuki Yoshida, Masanori Yasuda, Eito Kozawa, Keiichi Fujiwara
Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study. Journal of gynecologic oncology 28 (1) (2017)